nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

23.10.2015 | Head and Neck

Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases

verfasst von: Ingo U. Teudt, György Kovàcs, Matthias Ritter, Corinna Melchert, Tamer Soror, Barbara Wollenberg, Jens E. Meyer

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Recurrent neck metastases following surgery and full dose adjuvant radiotherapy of squamous cell head and neck cancer remain a clinical challenge. After revision neck dissection and chemotherapy re-irradiation dosage is often limited and survival prognosis deteriorates. Here, adjuvant high-dose rate intensity modulated perioperative brachytherapy (HDR IMBT) offers a second full radiation dose with a limited volume of normal tissue radiation in the neck. In this retrospective study patients were identified who underwent revision surgery and perioperative HDR IMBT for recurrent neck metastases. Survival rates were estimated and the scarce literature on interstitial brachytherapy of the neck was reviewed. From 2006 to 2014, nine patients were treated for recurrent or palliative neck metastases using salvage surgery and HDR IMBT. Eight patients received previous surgery and external beam radiotherapy with or without chemotherapy. Two and five year overall survival was calculated to be 78 and 67 %, respectively. HDR IMBT is a salvage treatment option for selected cases in the neck following surgical revision or last-line treatment strategies. In the literature and this small cohort radiation toxicity and the risk of “carotid blow-out” seemed to be low.

Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16:1310–1317PubMed

Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P et al (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081–2086CrossRefPubMed

Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098CrossRefPubMed

Argiris A (2002) Update on chemoradiotherapy for head and neck cancer. Curr Opin Oncol 14:323–329CrossRefPubMed

Hinerman RW, Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB (2004) Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 26:984–994CrossRefPubMed

Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993) Head and neck cancer. N Engl J Med 328:184–194CrossRefPubMed

Sher DJ, Haddad RI, Norris CM, Posner MR, Wirth LJ, Goguen LA et al (2010) Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer. Cancer 116:4761–4768CrossRefPubMed

Wierzbicka M, Bartochowska A, Strnad V, Strojan P, Mendenhall WM, Harrison LB et al (2014) The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck. Eur Arch Oto-Rhino-Laryngol. doi:10.1007/s00405-014-3332-8

Mazeron J-J, Ardiet J-M, Haie-Méder C et al (2009) GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol 91:150–156CrossRefPubMed

10.

Kovács G (2015) Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy. J Contemp Brachytherapy 6:404–416PubMed

11.

Strege R, Kovács G, Meyer J et al (2009) Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children. Strahlenther Onkol 185:789–798CrossRefPubMed

12.

Strege R, Kovács G, Maune S et al (2005) Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base. Strahlenther Onkol 181:97–107CrossRefPubMed

13.

Strege R, Kovács G, Lemcke P et al (2007) Role of perioperative brachytherapy in the treatment of malignancies invading the skull base and orbit. Neurosurg Quat 17:193–207CrossRef

14.

Teudt I, Meyer J, Ritter M (2014) Perioperative image- adapted brachytherapy for the treatment of paranasal sinus and nasal cavity malignancies. Brachytherapy 13:178–186CrossRefPubMed

15.

Strnad V, Lotter M, Kreppner S, Fietkau R (2014) Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma. Brachytherapy 13:187–195CrossRefPubMed

16.

Wiegand S, Sesterhenn AM, Zimmermann AP, Strassmann G, Wilhelm T, Werner JA (2013) Interstitial HDR brachytherapy for advanced recurrent squamous cell carcinoma of the head and neck. Anticancer Res 33:249–252PubMed

17.

Siebert F-A, Born T, Häring S et al (2006) A dosimetric analysis of interstitial intensity modulated implants for pelvic recurrences, base of tongue and orbita tumors with specific references to the ICRU-58. Radiother Oncol 79:298–303CrossRefPubMed

18.

Rudzianskas V, Inciura A, Juozaityte E, Rudzianskiene M, Kubilius R, Vaitkus S et al (2012) Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy. Acta Otorhinolaryngol Ital 32:297–303PubMedPubMedCentral

19.

Grimard L, Esche B, Lamothe A, Spaans JN (2009) Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy. Brachytherapy 8:284–289CrossRefPubMed

20.

Bartochowska A, Skowronek J, Wierzbicka M et al (2013) The role of high-dose-rate and pulsed-dose-rate brachytherapy in the management of recurrent or residual stomal tumor after total laryngectomy. Laryngoscope 123:657–661CrossRefPubMed

21.

Teckie S, Scala LM, Ho F, Wolden S, Chiu J, Cohen GN et al (2013) High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer. Brachytherapy 12:228–234CrossRefPubMed

22.

Scala LM, Hu K, Urken ML, Jacobson AS, Persky MS, Tran TN et al (2013) Intraoperative high-dose-rate radiotherapy in the management of locoregionally recurrent head and neck cancer. Head Neck 35:485–492CrossRefPubMed

23.

Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRef

24.

Common Terminology Criteria for Adverse Events (CTCAE). Natl Cancer Inst 2010. http://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf

25.

Cohen E, Lingen M, Vokes E (2004) The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 22:1743–1752CrossRefPubMed

26.

Hoo R, Grimard L, Esche B (1993) Brachytherapy of neck metastases. J Otolaryngol 22:54–57

27.

Wibault P, Chassagne D (1977) L’endocurithérapie des récidives ganglionnaires du cou par Iridium 192 (a propos de 164 cas). Nuovo Arch Ital Otol 5:389–396

28.

Cornes PG, Cox HJ, Rhys-Evans PR, Breach NM, Henk JM (1996) Salvage treatment for inoperable neck nodes in head and neck cancer using combined iridium-192 brachytherapy and surgical reconstruction. Br J Surg 83:1620–1622CrossRefPubMed

29.

Zelefsky M, Zimberg S, Raben A (1998) Brachytherapy for locally advanced and recurrent lymph node metastases. J Brachytherapy Int 14:123–131

30.

Nutting C, Horlock N, A’Hern R, Searle A, Henk JM, Rhys-Evans P et al (2006) Manually after-loaded 192Ir low-dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol 80:39–42CrossRefPubMed

31.

Syed AM, Feder BH, George FW, Neblett D (1978) Iridium-192 afterloaded implant in the retreatment of head and neck cancers. Br J Radiol 51:814–820CrossRefPubMed

32.

Bollet MA, Lapeyre M, Marchal C, Hoffstetter S, Peiffert D, Cornes PG et al (2001) Cervical lymph node relapses of head-and-neck squamous cell carcinoma: is brachytherapy a therapeutic option? Int J Radiat Oncol Biol Phys 51:1305–1312CrossRefPubMed

33.

Housset M, Barrett JM, Brunel P (1992) Split course interstitial brachytherapy with a source shift: the results of a new technique for salvage irradiation in recurrent inoperable cervical lymphadenopathy >4 cm diameter in 23 patients. Int J Radiat Oncol Biol Phys 22:1071–1074CrossRefPubMed

34.

Tselis N, Ratka M, Vogt H-G, Kolotas C, Baghi M, Baltas D et al (2011) Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol 98:57–62CrossRefPubMed

35.

Kolotas C, Tselis N, Sommerlad M (2007) Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192 Ir HDR brachytherapy. Strahlenther Onkol 183:69–75CrossRefPubMed

36.

Pellizzon ACA, Salvajoli JV, Kowalski LP, Carvalho AL (2006) Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy. Radiat Oncol 1:27CrossRefPubMedPubMedCentral

37.

Kupferman ME, Morrison WH, Santillan AA, Roberts D, Diaz EM, Garden AS et al (2007) The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers. Cancer 109:2052–2057CrossRefPubMed

38.

Fee WE, Goffinet DR, Paryani S, Goode RL, Levine PA, Hopp ML (1983) Intraoperative iodine 125 implants. Arch Otolaryngol 109:727–730CrossRefPubMed

39.

Stafford N, Dearnaley D (1988) Treatment of ‘inoperable’ neck nodes using surgical clearance and postoperative interstitial irradiation. Br J Surg 75:62–64CrossRefPubMed

40.

Geiger EJ, Basques BA, Chang CC, Alcon AW, Narayan D (2014) Wound healing complications with intraoperative brachytherapy for head and neck cancer. Ann Plast Surg 73:378–384CrossRefPubMed

41.

Nijdam W, Levendag P, Fuller D, Schulz R, Prevost J-B, Noever I et al (2007) Robotic radiosurgery vs. brachytherapy as a boost to intensity modulated radiotherapy for tonsillar fossa and soft palate tumors: the clinical and economic impact of an emerging technology. Technol Cancer Res Treat 6:611–620CrossRefPubMed

42.

Tagliaferri L, Bussu F, Rigante M, Gambacorta MA, Autorino R, Mattiucci GC et al (2015) Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences. Brachytherapy 14:419–425CrossRefPubMed

Titel: Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases
verfasst von: Ingo U. Teudt
György Kovàcs
Matthias Ritter
Corinna Melchert
Tamer Soror
Barbara Wollenberg
Jens E. Meyer
Publikationsdatum: 23.10.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 9/2016
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-015-3794-3

Neu im Fachgebiet HNO

16.04.2024 | HNO-Chirurgie | Nachrichten

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases

Abstract

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2016

Quality of life in functional rhinoplasty: rhinoplasty outcomes evaluation German version (ROE-D)

Otological complications associated with hyperbaric oxygen therapy

Clinical and surgical implications regarding morphometric variations of the medial wall of the orbit in relation to age and gender

Rapid review: sinonasal surgery vs. medical therapy for asthma in patients with chronic rhinosinusitis with or without nasal polyps

Is age a limiting factor for adaptation to cochlear implant?

Quantification of lymph nodes in the central compartment of the neck: a cadaveric study

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO